Navigation Links
NASA Nanosatellite to Study Antifungal Drug Effectiveness in Space
Date:4/28/2009

MOFFETT FIELD, Calif., April 28 /PRNewswire-USNewswire/ -- NASA is preparing to fly a small satellite about the size of a loaf of bread that could help scientists better understand how effectively drugs work in space. The nanosatellite, known as PharmaSat, is a secondary payload aboard a U.S. Air Force four-stage Minotaur 1 rocket planned for launch the evening of May 5.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO)

PharmaSat weighs approximately 10 pounds. It contains a controlled environment micro-laboratory packed with sensors and optical systems that can detect the growth, density and health of yeast cells and transmit that data to scientists for analysis on Earth. PharmaSat also will monitor the levels of pressure, temperature and acceleration the yeast and the satellite experience while circling Earth at 17,000 miles per hour. Scientists will study how the yeast responds during and after an antifungal treatment is administered at three distinct dosage levels to learn more about drug action in space, the satellite's primary goal.

The Minotaur 1 rocket is on the launch pad at NASA's Wallops Flight Facility and the Mid-Atlantic Regional Spaceport located at Wallops Island, Va. The Wallops range is conducting final checkouts. The U.S. Air Force has announced that the rocket could launch at any time during a three-hour launch window beginning at 8 p.m. EDT May 5.

"Secondary payload nanosatellites expand the number of opportunities available to conduct research in microgravity by providing an alternative to the International Space Station or space shuttle conducted investigations," said Elwood Agasid, PharmaSat project manager at NASA's Ames Research Center in Moffett Field, Calif. "The PharmaSat spacecraft builds upon the GeneSat-1 legacy with enhanced monitoring and measurement capabilities, which will enable more extensive scientific investigation."

After PharmaSat separates from the Minotaur 1 rocket and successfully enters low Earth orbit at approximately 285 miles above Earth, it will activate and begin transmitting radio signals to two ground control stations. The primary ground station at SRI International in Menlo Park, Calif., will transmit mission data from the satellite to the spacecraft operators in the mission control center at NASA's Ames Research Center. A secondary station is located at Santa Clara University in Santa Clara, Calif.

When NASA spaceflight engineers make contact with PharmaSat, which could happen as soon as one hour after launch, the satellite will receive a command to initiate its experiment, which will last 96 hours. Once the experiment begins, PharmaSat will relay data in near real-time to mission managers, engineers and project scientists for further analysis. The nanosatellite could transmit data for as long as six months.

"PharmaSat is an important experiment that will yield new information about the susceptibility of microbes to antibiotics in the space environment," said David Niesel, PharmaSat's co-investigator from the University of Texas Medical Branch Department of Pathology and Microbiology and Immunology in Galveston. "It also will prove that biological experiments can be conducted on sophisticated autonomous nanosatellites."

As with NASA's previous small satellite missions, such as the GeneSat-1, which launched in 2006 and continues to transmit a beacon to Earth, Santa Clara University invites amateur radio operators around the world to tune in to the satellite's broadcast.

For more information and instructions about how to contact PharmaSat, visit:

http://www.nasa.gov/mission_pages/smallsats/pharmasat.html

To view the launch via webcast, visit:

http://sites.wff.nasa.gov/webcast

For the more information about PharmaSat and other small satellite missions, visit:

http://www.nasa.gov/mission_pages/smallsats


'/>"/>
SOURCE NASA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
Breaking Medicine Technology: